Found: 13
Select item for more details and to access through your institution.
<sup>18</sup>F‐FDG PET/CT imaging in neuroendocrine prostate cancer: Relation to histopathology and prognosis.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1167, doi. 10.1002/pros.24559
- By:
- Publication type:
- Article
<sup>18</sup>F‐sodium fluoride positron emission tomography quantitation of bone metastases in African American and non‐African American men with metastatic prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1193, doi. 10.1002/pros.24578
- By:
- Publication type:
- Article
Test–retest repeatability of organ uptake on PSMA‐targeted <sup>18</sup>F‐DCFPyL PET/CT in patients with prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1186, doi. 10.1002/pros.24577
- By:
- Publication type:
- Article
Evaluation of a photodynamic therapy agent using a canine prostate cancer model.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1176, doi. 10.1002/pros.24560
- By:
- Publication type:
- Article
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1127, doi. 10.1002/pros.24582
- By:
- Publication type:
- Article
Proapoptotic effect of nonthermal pulsed ultrasound on prostate cancer cells in a nude mouse model.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1217, doi. 10.1002/pros.24581
- By:
- Publication type:
- Article
Trends in prostate cancer incidence among Black men in the Caribbean and the United States.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1207, doi. 10.1002/pros.24580
- By:
- Publication type:
- Article
PSMA guided approach for bIoCHEmical relapse after prostatectomy‐ (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga‐PSMA PET/CT within a prospective study.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1201, doi. 10.1002/pros.24579
- By:
- Publication type:
- Article
Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1158, doi. 10.1002/pros.24558
- By:
- Publication type:
- Article
Upgrading on Per Protocol versus For Cause surveillance prostate biopsies: An opportunity to decreasing the burden of active surveillance.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1141, doi. 10.1002/pros.24556
- By:
- Publication type:
- Article
Validation of the prognostic value of a three‐gene signature and clinical parameters‐based risk score in prostate cancer patients.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1133, doi. 10.1002/pros.24530
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1125, doi. 10.1002/pros.24390
- Publication type:
- Article
Post‐diagnostic metformin and statin use and risk of biochemical recurrence in Veterans diagnosed with prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 12, p. 1150, doi. 10.1002/pros.24557
- By:
- Publication type:
- Article